Pharmaceutical Pricing Reform, an Open Discussion

Event description
Pricing of pharmaceuticals in the United States has been, and continues to be, a polarizing issue of wide reaching impact in our industry. Many headlines have highlighted drugs with significant price increases and noted more generally the high price of curative medicines with restricted reimbursement. Advocates for price controls say these prices are unsustainable and something has to change. However, pharmaceutical companies invest more in research and development relative to sales than any other manufacturing industry – more than 18% which is six times the average of most companies. This is a system with a high failure rate and one in which pricing for one drug is paying the development costs for many other failed drugs. When competition hasn’t entered the market due to quality issues or level of manufacturing complexity, manufacturers want to be rewarded for their innovations.

Drug pricing, like other goods, should account for the risk incurred, but also have a measure of fair value and transparency of outcomes delivered. But the question is, how do we define “value”? The value of drugs may vary significantly from medication to medication, what’s being treated and outcomes delivered. Add in curative drugs and it becomes increasingly difficult to value the years, months or even days added to a patient’s life.

Please join us on the campus of Express Scripts as we hear from Kim White of Numerof & Associates as she leads a panel of experts in a discussion on this very topical issue. They will discuss the different models being considered, their challenges and opportunities, as well as the impact each presents to manufacturers, providers, payers and patients.

Learning objectives
1. Understand the evolution and current state of pharmaceutical pricing in the US and how it impacts healthcare manufacturers, providers and other stakeholders
2. Understand the challenges and opportunities different models present to manufacturers, payers, providers and patients

Agenda
7:30 - 8:00 AM   Registration and networking breakfast
8:00 - 8:15 AM   Welcome and introduction
8:15 - 9:30 AM   Pharmaceutical Pricing Reform, an Open Discussion

Event location
Express Scripts, Building 4 (Room 1074/1075)
8640 Evans Ave.
St. Louis, MO 63121
314-996-0900

Directions

Special instructions: The building is located across highway 70 from the main campus, next to Vatterott College. Exit highway 70 at Hanley and head north on Hanley. Turn right at first light, which is Evans and Express Scripts is on the left.

Sponsors

Speaker
Kimberly White, MBA (moderator)
Vice president, Numerof & Associates

Registration information
Event is open to: HBA members and nonmembers
Online registration deadline: October 24, 2016
Onsite (walk-in) registration: Is allowed

Member rate:
$29 until October 20, 2016
$39 after October 20, 2016

Nonmember rate:
$45 until October 20, 2016
$55 after October 20, 2016

Space is limited to 125 registrants.

Cancellations/refunds
Is this event refundable? Yes
If yes, requests must be submitted in writing to events@hbanet.org by October 20, 2016; no refunds are available after this date.

Event questions/support
- Chapter contact for event: Susan Kronemer at kronemertravel@gmail.com or 314-498-0641
- Membership questions: membership@hbanet.org or 973-575-0606 ext 1
- Online registration assistance: events@hbanet.org or 973-575-0606 ext 3

Visit us online

Pricing

	Member	Non-Member
Regular registration	$39.00 / €33.00	$55.00 / €47.00

Members receive up to 50 percent discount

Event Policies

Photography Policy
By registering for this event, you acknowledge that you may be photographed, videotaped, and/or audio-taped during the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion, and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.

COVID-19 Policy
The HBA requires that all persons who participate in in-person events do so at their own risk and that each participant agrees to the following agreement before taking part in the activity and urges all participants to act in such a manner as to protect their own safety and the safety of others.

By registering for this event, I fully understand that my participation in the program is purely voluntary. I desire to participate and agree to act reasonably and prudently under the circumstances. I further understand that any HBA volunteers participating in the activity will act individually and will not represent the HBA. As a condition to my participation the activity, I waive and release the HBA and their officers, employees, and agents from any claim that I may have for any damage to property or injury to my person that may result in whole or in part from my participation.

Special Needs Policy
The HBA will make reasonable modifications to policies and programs to ensure that people with special needs can enjoy all of its programs. Contact us if you require special accommodations for this event.